On June 12, 2024, the company announced an increase in its equity buyback plan. The company increased its authority by CNY 100 million, thereby bringing the total authorization to CNY 500 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.31 CNY | +0.36% | +3.36% | -38.12% |
07-03 | Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023. | CI |
06-12 | ChenGuang Biotech Group Co., Ltd. announces an Increase in Equity Buyback. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.12% | 585M | |
-5.01% | 273B | |
-9.11% | 86.32B | |
-0.48% | 41B | |
-11.20% | 39.21B | |
+1.89% | 38.21B | |
-3.44% | 35.09B | |
-10.61% | 31.35B | |
-1.97% | 30.03B | |
+4.10% | 23.79B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- ChenGuang Biotech Group Co., Ltd. announces an Increase in Equity Buyback.